Is a complete CV research report available?

No complete published report is available for CapsoVision, Inc. (CV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CapsoVision, Inc. (CV)

NASDAQ: CV · USD

$7.09

+0.34 (+5.0%)· Recorded snapshot

Market cap	354.8M
Revenue (ttm)	13.9M
Net income (ttm)	-29.8M
EPS (ttm)	-$0.62
Shares out	50M
Volume	156,879

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 13.9M
Net income (ttm): -29.8M
EPS (ttm): -$0.62
Market cap: 354.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantenere

Metric	Value
Amount currency	USD
CIK code	0001378325
Company name	CapsoVision, Inc.
Country	United States
Country code	US
CUSIP number	140935107
Earnings date	2026-11-12
Earnings time	amc
Employees	99
Employees change	9
Employees growth	10%
Enterprise value	$346.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2005
In index	RUSSELL2000
Industry	Medical Devices
IPO date	2025-07-02
Is primary listing	Yes
Is SPAC	No
ISIN number	US1409351079
Last 10-K release date	2026-03-26
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$354.8M
Market cap category	Small-Cap
Next earnings date	2026-11-12
Options	No
Price	$7.09
Price currency	USD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	CV
U.S. state	California
Website	https://capsovision.com

Metric

Value

Amount currency

USD

CIK code

0001378325

Company name

CapsoVision, Inc.

Country

United States

Country code

CUSIP number

140935107

Earnings date

2026-11-12

Earnings time

amc

Employees

Employees change

Employees growth

10%

Enterprise value

$346.4M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2005

In index

RUSSELL2000

Industry

Medical Devices

IPO date

2025-07-02

Is primary listing

Yes

Is SPAC

ISIN number

US1409351079

Last 10-K release date

2026-03-26

Last earnings date

2026-08-13

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$354.8M

Market cap category

Small-Cap

Next earnings date

2026-11-12

Options

Price

$7.09

Price currency

USD

Sector

Healthcare

SIC code

3845

Stock price date

2026-10-28

Symbol

U.S. state

California

Website

https://capsovision.com

Metric	Value
Earnings yield	-8.8%
EV/Sales	24.72x
FCF / EV yield	-8.12%
FCF yield	-7.93%
Forward EV/Sales	20.3x
Forward P/S	20.79x
Industry forward P/E	19.81x
Industry P/E	39.28x
P/B ratio	25.65x
P/S ratio	25.33x
Price / tangible book value	26.72x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-8.8%

EV/Sales

24.72x

FCF / EV yield

-8.12%

FCF yield

-7.93%

Forward EV/Sales

20.3x

Forward P/S

20.79x

Industry forward P/E

19.81x

Industry P/E

39.28x

P/B ratio

25.65x

P/S ratio

25.33x

Price / tangible book value

26.72x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-214.51%
EBITDA margin	-212.9%
Gross margin	50.88%
Operating margin	-214.51%
Pretax margin	-214.56%
Profit margin	-214.74%
Profit per employee	$-301,303
Revenue per employee	$140,313
ROA	-132.47%
ROCE	-222.18%
ROE	-335.06%
ROIC	-181.18%
SBC / revenue	10.19%
Tax / revenue	0.17%

Metric

Value

EBIT margin

-214.51%

EBITDA margin

-212.9%

Gross margin

50.88%

Operating margin

-214.51%

Pretax margin

-214.56%

Profit margin

-214.74%

Profit per employee

$-301,303

Revenue per employee

$140,313

ROA

-132.47%

ROCE

-222.18%

ROE

-335.06%

ROIC

-181.18%

SBC / revenue

10.19%

Tax / revenue

0.17%

Metric	Value
EPS growth quarters	5
EPS growth years	1
Gross profit growth	5.56%
Gross profit growth (Q)	3.31%
Net income growth years	0
Revenue growth	10.99%
Revenue growth (Q)	9.89%
Revenue growth (QoQ)	30.48%
Revenue growth quarters	6
Revenue growth years	2

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

5.56%

Gross profit growth (Q)

3.31%

Net income growth years

Revenue growth

10.99%

Revenue growth (Q)

9.89%

Revenue growth (QoQ)

30.48%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-68,000
Depreciation and amortization	$223,000
EBIT	$-29.8M
EBITDA	$-29.6M
EPS	$-0.62
FCF per share	$-0.56
Financing cash flow	$35.9M
Free cash flow	$-27.9M
Free cash flow minus SBC	$-29.3M
Gross profit	$7.1M
Income taxes	$24,000
Investing cash flow	$-68,000
Net borrowing	$-1M
Net cash flow	$8M
Net income	$-29.8M
Operating cash flow minus SBC	$-29.2M
Operating income	$-29.8M
Revenue	$13.9M
Stock-based compensation	$1.4M

Metric

Value

Capital expenditures

$-68,000

Depreciation and amortization

$223,000

EBIT

$-29.8M

EBITDA

$-29.6M

EPS

$-0.62

FCF per share

$-0.56

Financing cash flow

$35.9M

Free cash flow

$-27.9M

Free cash flow minus SBC

$-29.3M

Gross profit

$7.1M

Income taxes

$24,000

Investing cash flow

$-68,000

Net borrowing

$-1M

Net cash flow

$8M

Net income

$-29.8M

Operating cash flow minus SBC

$-29.2M

Operating income

$-29.8M

Revenue

$13.9M

Stock-based compensation

$1.4M

Metric	Value
Altman Z-Score	12.71
Book value per share	$0.26
Debt / equity	0.05
Long-term assets	$1.3M
Long-term liabilities	$245,000
Net cash (debt)	$8.4M
Net cash / market cap	2.38%
Net debt / equity	-0.64
Piotroski F-Score	2
Property, plant and equipment	$1.2M
Shareholders' equity	$13.2M
Tangible book value	$13.2M
Tangible book value per share	$0.26
Total assets	$18.6M
Total cash	$9.1M
Total debt	$687,000
Total liabilities	$5.4M

Metric

Value

Altman Z-Score

12.71

Book value per share

$0.26

Debt / equity

0.05

Long-term assets

$1.3M

Long-term liabilities

$245,000

Net cash (debt)

$8.4M

Net cash / market cap

2.38%

Net debt / equity

-0.64

Piotroski F-Score

Property, plant and equipment

$1.2M

Shareholders' equity

$13.2M

Tangible book value

$13.2M

Tangible book value per share

$0.26

Total assets

$18.6M

Total cash

$9.1M

Total debt

$687,000

Total liabilities

$5.4M

Metric	Value
Asset turnover	0.99
Current assets	$17.3M
Current liabilities	$5.2M
Current ratio	3.35
Inventory turnover	1.59
Net working capital	$3.5M
Quick ratio	2.2
Working capital	$12.1M
Working capital turnover	1.77

Metric

Value

Asset turnover

0.99

Current assets

$17.3M

Current liabilities

$5.2M

Current ratio

3.35

Inventory turnover

1.59

Net working capital

$3.5M

Quick ratio

2.2

Working capital

$12.1M

Working capital turnover

1.77

Metric	Value
Buyback yield / dilution	-2,118.22%
Dividend yield	0%
Shareholder yield	-2,118.22%

Metric

Value

Buyback yield / dilution

-2,118.22%

Dividend yield

Shareholder yield

-2,118.22%

Metric	Value
150-day SMA	$6.61
1D price change	5.04%
1M price change	6.92%
1M total return	6.92%
1W price change	6.44%
1W total return	6.44%
1Y price change	46.3%
1Y return CAGR	46.33%
1Y total return	46.3%
20-day SMA	$6.66
200-day SMA	$6.34
3M price change	7.56%
3M total return	7.56%
50-day SMA	$6.39
50-day SMA vs 200-day SMA	50over200
52-week high	$15.37
52-week high date	2025-12-11
52-week low	$4.50
52-week low date	2026-02-20
6M price change	11.62%
6M total return	11.62%
All-time high	$15.37
All-time high date	2025-12-11
All-time low	$3.43
All-time low date	2025-09-08
Average true range (ATR)	$0.31
Average volume	119.6K
Beta (1Y)	-2.05
Beta (2Y)	-1.35
Change from 52-week high	-53.87%
Change from 52-week low	57.56%
Change from all-time high	-53.74%
Change from all-time low	107.05%
Change from open	3.96%
Day's gap	1.04%
Dollar volume	$1.1M
High price	$7.11
Low price	$6.82
Monthly RSI	60
Open price	$6.82
Position in 52-week range	93.1%
Previous close	$6.75
Price vs 150-day SMA	7.25%
Price vs 20-day SMA	6.49%
Price vs 200-day SMA	11.79%
Price vs 50-day SMA	10.95%
Relative volume	1.31
Return from IPO open	40.6%
Return from IPO price	40.6%
RSI	61.48
Sharpe ratio	0.82
Sortino ratio	1.41
Volume	156.9K
Weekly RSI	55.33
YTD price change	-33.49%
YTD total return	-33.49%

Metric

Value

150-day SMA

$6.61

1D price change

5.04%

1M price change

6.92%

1M total return

6.92%

1W price change

6.44%

1W total return

6.44%

1Y price change

46.3%

1Y return CAGR

46.33%

1Y total return

46.3%

20-day SMA

$6.66

200-day SMA

$6.34

3M price change

7.56%

3M total return

7.56%

50-day SMA

$6.39

50-day SMA vs 200-day SMA

50over200

52-week high

$15.37

52-week high date

2025-12-11

52-week low

$4.50

52-week low date

2026-02-20

6M price change

11.62%

6M total return

11.62%

All-time high

$15.37

All-time high date

2025-12-11

All-time low

$3.43

All-time low date

2025-09-08

Average true range (ATR)

$0.31

Average volume

119.6K

Beta (1Y)

-2.05

Beta (2Y)

-1.35

Change from 52-week high

-53.87%

Change from 52-week low

57.56%

Change from all-time high

-53.74%

Change from all-time low

107.05%

Change from open

3.96%

Day's gap

1.04%

Dollar volume

$1.1M

High price

$7.11

Low price

$6.82

Monthly RSI

Open price

$6.82

Position in 52-week range

93.1%

Previous close

$6.75

Price vs 150-day SMA

7.25%

Price vs 20-day SMA

6.49%

Price vs 200-day SMA

11.79%

Price vs 50-day SMA

10.95%

Relative volume

1.31

Return from IPO open

40.6%

Return from IPO price

40.6%

RSI

61.48

Sharpe ratio

0.82

Sortino ratio

1.41

Volume

156.9K

Weekly RSI

55.33

YTD price change

-33.49%

YTD total return

-33.49%

Metric	Value
Float	28M
Float percentage	55.91%
Shares change (QoQ)	5.23%
Shares change (YoY)	2,118.22%
Shares held by insiders	37.2%
Shares held by institutions	10.43%
Shares outstanding	50M
Short % of float	7.52%
Short % of shares	4.2%
Short ratio	7.7 days

Metric

Value

Float

28M

Float percentage

55.91%

Shares change (QoQ)

5.23%

Shares change (YoY)

2,118.22%

Shares held by insiders

37.2%

Shares held by institutions

10.43%

Shares outstanding

50M

Short % of float

7.52%

Short % of shares

4.2%

Short ratio

7.7 days

CapsoVision, Inc. (CV)

Price

Financial snapshot

Fair-value bridge

Latest news · CV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CV

Frequently asked questions